![]()
|
|
||||||||
J Biol Chem, Vol. 274, Issue 38, 26901-26906, September 17, 1999
,
,
, and
**
From the
Department of Zoology and the
Institute of Biochemistry, National Chung Hsing
University, Taichung, Taiwan, Republic of China, the
§ Section of Nephrology, Taichung Veterans General Hospital,
Taichung, Taiwan, Republic of China, and the ¶ Department of
Physiology, National Cheng Kung University Medical College,
Tainan, Taiwan, Republic of China
| |
ABSTRACT |
|---|
|
|
|---|
Focal adhesion kinase (FAK) has been implicated
to play a role in suppression of apoptosis. In this study, we have
demonstrated that UV irradiation induced cleavage of FAK and two of its
interacting proteins Src and p130Cas in Madin-Darby
canine kidney cells, concomitant with an increase in cell death. The
cleavage of these proteins upon UV irradiation was completely inhibited
by ZVAD-FMK, a broad range inhibitor of caspases, and apparently
delayed by Bcl2 overexpression. To examine if FAK plays a role in
suppressing UV-induced apoptosis, stable Madin-Darby canine kidney cell
lines overexpressing FAK were established. Our results showed that a
marked (30-40%) increase in cell survival upon UV irradiation was
achieved by this strategy. In our efforts to determine the mechanism by
which FAK transduces survival signals to the downstream, we found that
a FAK mutant deficient in binding to phosphatidylinositol 3-kinase
failed to promote cell survival. Moreover, the expression of the Src
homology 3 domain of p130Cas, which competed with
endogenous p130Cas for FAK binding, abrogated the
FAK-promoted cell survival. Together, these results suggest that the
integrity of FAK and its binding to phosphatidylinositol 3-kinase and
p130Cas are required for FAK to exert its antiapoptotic function.
Focal adhesion kinase
(FAK),1 a 125-kDa cytoplasmic
tyrosine kinase localized in focal adhesions, is a key component in
integrin-mediated signal transduction pathways (1-3). So far, FAK has
been implicated to play an important role in regulating at least three
aspects of cellular functions, including cell migration (4, 5), cell
cycle progression (6), and cell survival (7-10). The ability of FAK to
transduce signals to the downstream is believed to be dependent on its
ability to interact with several intracellular signaling molecules
including Src family kinases (11, 12), phosphatidylinositol 3-kinase
(PI3K; Ref. 13), Grb2 (14), and p130Cas (15). It has been
shown recently that two simultaneous bindings of PI3K and
p130Cas are required for FAK to promote cell migration on
extracellular matrix proteins (16, 17). However, it is not clear if any of these molecules are responsible for the function of FAK in cell
cycle or cell survival.
Tyr-397 has been identified as the major site of FAK
autophosphorylation (18) and the binding site for the Src homology 2 (SH2) domains of Src (11, 12) and PI3K (19). The binding site for the
SH2 domain of Grb2 has been mapped to Tyr-925 (20). The proline-rich
sequence region of FAK (residues 712-718) has been identified as the
major binding site for the SH3 domain of p130Cas (15, 21).
A substitution of Tyr-397 with Phe was found to abrogate the binding of
FAK to both Src and PI3K (19). To directly analyze the effect of the
loss of PI3K binding on FAK's functions, a FAK mutant deficient only
in PI3K binding has recently been introduced by a substitution of
Asp-395 with Ala (17).
Several lines of evidence have suggested that FAK may have a function
in promoting cell survival. Inhibition of FAK in fibroblasts by
microinjection with anti-FAK antibodies or with a peptide corresponding to a region of In this report, we have demonstrated that FAK is a target of caspases
during UV-induced apoptosis and that overexpression of the wild-type
(WT) FAK is capable of suppressing cell death upon UV irradiation.
Moreover, we have found that inhibition of the association of FAK with
PI3K or p130Cas abrogates the ability of FAK to promote
cell survival. Taken together, these results strongly suggest that
signals transmitted through the associations of FAK with PI3K and
p130Cas are important for cell survival.
Expression Plasmids and Antibodies--
The mammalian expression
plasmid pKH3 encoding hemagglutinin (HA) epitope-tagged WT FAK or its
mutants (D395A, Y397F, P712A/P715A, and Y925F) have been described
previously (17). The plasmid pKH3-CasSH3 encoding the HA epitope-tagged
SH3 domain of p130Cas was kindly provided by Dr. J.-L. Guan
(Cornell University, Ithaca, NY) and described previously (16).
The anti-FAK mAb (clone 77) was purchased form Transduction
Laboratories (Lexington, KY). The rabbit polyclonal
anti-p130Cas (C-20) was purchased from Santa Cruz
Biotechnology, Inc. (Santa Cruz, CA). The anti-Src monoclonal antibody
(05-184) was purchased form Upstate Biotechnology, Inc. (Lake Placid,
NY). The rabbit polyclonal anti-p85 and the monoclonal antibody 12CA5
(anti-HA) have been described previously (19).
Cells and Transfections--
MDCK cells, clone 3B5, were
maintained in Dulbecco's modified Eagle's medium supplemented with
10% fetal bovine serum (Life Technologies, Inc.). To generate cells
stably expressing HA epitope-tagged FAK, subconfluent MDCK cells grown
on 60-mm dishes were co-transfected with 2 µg of pKH3 plasmid
encoding WT FAK or its mutant and 0.2 µg of pSV2neo using 10 µl of
LipofectAMINE (Life Technologies, Inc.). Two days after transfection,
cells were detached and replated on 100-mm dishes at an appropriate
density in the medium containing 0.5 mg/ml of G418 (Calbiochem). After
approximately 14 days, neomycin-resistant cell clones were picked using
cloning cylinders and screened for exogenous FAK expression by
immunoblotting using monoclonal antibody anti-HA. Multiple positive
clones were obtained for further analysis for each FAK constructs.
Stable MDCK cells overexpressing Bcl2 have been described previously
(22) and were maintained in G418-containing medium.
To generate MDCK cells stably expressing both FAK and CasSH3, WT cells
were transfected as described above using LipofectAMINE, 2 µg of
pKH3-CasSH3, and 0.2 µg of pREP3. Clones were selected in growth
medium containing 0.5 mg/ml G418 and 125 units/ml Hygromycin B
(Calbiochem) and screened for FAK and CasSH3 expression by
immunoblotting with anti-HA.
UV Irradiation, Treatment of Caspase Inhibitors, and
Determinations of Cell Survival and Apoptotic Index--
For UV
irradiation, MDCK cells were plated at 106 per 60-mm
culture dish in growth medium. After 12 h, the medium was reduced to 1 ml/dish, and culture dishes were uncovered in an UV cross-linker (model UVC-508, ULTRA-LUM Inc., Carson, CA). UV irradiation was carried
out with 10 mJ/cm2 for 1 min. Following irradiation, 2 ml
of growth medium was added, and the cells were incubated at 37 °C
for the indicated times in a CO2 incubator. For some
experiments, cells were pretreated with 40 µM caspase
inhibitor ZVAD-FMK or DEVD-CHO (Takara Shuzo Co., Shiga, Japan) for
1 h. Following UV irradiation, cells were incubated in growth
medium with freshly added caspase inhibitor for 12 h.
Cell viability was determined by trypan blue exclusion. Briefly,
UV-irradiated cells were collected and washed once with
phosphate-buffered saline. Cell suspensions in phosphate-buffered
saline were mixed with an equal volume of 0.4% trypan blue (Sigma),
and cells excluding dye were counted with a hemocytometer. Cell
survival was expressed as the percentage of live cells remaining after
UV irradiation compared with the cell number at the time right before
UV irradiation.
For nuclear staining, cells (104) were plated on glass
coverslips for 16 h and then exposed to UV radiation. After 4 h, coverslips were washed with phosphate-buffered saline, fixed in 4%
paraformaldehyde, and stained with 0.5 µg/ml Hoechst 33258 (Sigma).
Normal nuclei and apoptotic nuclei comprising those with fragmented
nuclei and condensed chromatin in 10 randomly chosen fields were
counted under a fluorescent microscope at × 40 magnification.
Apoptotic index was expressed as the percentage of apoptotic nuclei in
total counted (200-300) nuclei.
Immunoprecipitations, Immunoblotting, and in Vitro Kinase
Assays--
To analyze protein cleavage, UV-irradiated cells were
collected and lysed in 1% Nonidet P-40 lysis buffer containing
protease inhibitors as described previously (23). An equal amount (50 µg) of lysates was resolved by SDS-polyacrylamide gel electrophoresis and analyzed by immunoblotting with anti-FAK, anti-p130Cas,
anti-Src, anti-p85, or anti-HA using the Amersham Pharmacia Biotech
chemiluminescence system for detection.
To measure the PI3K activity associated with ectopically expressed FAK
proteins in MDCK cells, epitope-tagged FAK proteins were
immunoprecipitated with anti-HA from MDCK cell lysates (700 µg) and
subjected to an in vitro PI3K assay as described previously (13).
To detect the association of epitope-tagged FAK with endogenous
p130Cas in MDCK cells, lysates (500 µg) were incubated
with polyclonal anti-p130Cas. The immunocomplexes were
washed with 1% Nonidet P-40 lysis buffer and analyzed by
immunoblotting with anti-HA.
A proteolytic cleavage of FAK has been observed during apoptosis
induced by serum deprivation (24), the addition of Fas ligand/Apo-2L
(25), overexpression of c-Myc (26), and treatment of certain chemicals
such as staurosporine (27). In this report, we have examined if FAK
cleavage also occurs during UV-induced apoptosis. Similar to other
apoptotic stimuli as described above, UV irradiation induced a
sequential cleavage of FAK into two fragments in MDCK cells, which was
concomitant with a decrease in cell survival (Fig.
1). The first cleavage product of the
85-kDa fragment was detected as early as 6 h after UV irradiation,
and the second cleavage product of 77-kDa fragment was detected 3 h later. Twenty-four hours after UV irradiation, dead cells accounted
for more than 95% of the total cell population in which the intact FAK
was not detected, and only the 77-kDa fragment remained. In addition to FAK, we also examined if other cellular proteins that are known to
interact with FAK undergo cleavage during UV-induced apoptosis (Fig.
1). Among these proteins, we found that the amount of
p130Cas was gradually decreased 6 h after UV
irradiation, presumably due to a proteolytic cleavage, and finally
disappeared at 24 h. In addition, the cleavage of Src upon UV
irradiation was found to generate an approximately 50-kDa fragment.
Interestingly, a significant amount of Src remained intact 24 h
after UV irradiation, indicating that Src was only partially cleaved
during the apoptotic response. In contrast, the level of four
other FAK-interacting proteins including the p85 subunit of PI3K (Fig.
1), Grb2, paxillin, and talin had no detectable change during
UV-induced apoptosis (data not shown).
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
1 integrin cytoplasmic domain thought to
be required for FAK binding results in apoptosis (7). Similarly,
attenuation of FAK expression by antisense oligonucleotides induces
apoptosis in tumor cells (8). Recently, Ilic et al. (9)
suggested that survival signals from extracellular matrix transduced by FAK may suppress p53-mediated apoptosis and showed that expression of a
FAK C-terminal construct, the focal adhesion targeting (FAT) domain,
induces apoptosis in primary fibroblasts. Finally, expression of the
constitutively activated form of FAK (CD2-FAK) by anchoring it to the
plasma membrane prevents epithelial cells from apoptosis upon cell
detachment (10).
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

View larger version (62K):
[in a new window]
Fig. 1.
Cleavage of FAK and its interacting proteins
during UV-induced apoptosis. MDCK cells were exposed to UV
radiation with 10 mJ/cm2 for 1 min. After various times as
indicated, live cells were determined by trypan blue exclusion. Cell
survival is expressed as the percentage of live cells remaining
compared with the cell number at the time right before UV irradiation
(0 h), which is defined as 100%. Values are the average of three
independent experiments. To examine protein cleavage, an equal amount
(50 µg) of lysates prepared from UV-irradiated cells was analyzed by
immunoblotting with anti-FAK, anti-p130Cas, anti-Src, or
anti-p85.
To examine if caspases are involved in the cleavage of FAK,
p130Cas, and Src during UV-induced apoptosis, UV-exposed
MDCK cells were incubated with tetrapeptide caspase inhibitors,
ZVAD-FMK or DEVD-CHO (Fig.
2A). ZVAD-FMK, a general
inhibitor of cysteine proteases, completely blocked cleavage of FAK,
p130Cas, and Src, and significantly (~30%) increased
cell survival upon UV irradiation. DEVD-CHO, a specific inhibitor of
caspase-3, at a concentration of 40 µM was able to
completely block Src cleavage but only partially inhibit the cleavage
of FAK and p130Cas. These results suggest that the cleavage
of FAK and p130Cas is likely to be mediated by more than
one member of caspase family during UV irradiation-induced
apoptosis.
|
The expression of Bcl2 has been shown to suppress apoptosis by inhibiting the activation of caspases (28, 29). To determine whether Bcl2 blocks FAK cleavage in response to UV irradiation, stable MDCK cell lines overexpressing Bcl2 were established (22). The expression level of ectopic Bcl2 in MDCK cells was at least 10-fold higher than endogenous Bcl2 (data not shown). The Bcl2-overexpressed (Bcl2) cells and control (Neo) cells were exposed to UV radiation and then analyzed for FAK cleavage after various time intervals. The results showed that overexpression of Bcl2 in MDCK cells apparently delayed FAK cleavage upon UV irradiation (Fig. 2B). The first FAK cleavage product of the 85-kDa fragment appeared at 12 h after UV irradiation in Bcl2-overexpressed cells, which was an approximately 6-h delay compared with control cells. Consistent with the results from parental MDCK cells (Fig. 1), no intact FAK could be detected in Neo control cells 24 h after UV irradiation. Notably, at this time point, a significant amount of intact FAK still remained in Bcl2-overexpressed cells.
To examine if FAK plays a role in preventing UV-induced cell death,
stable MDCK cell lines overexpressing HA-tagged FAK (WT) were
established. The expression level of ectopic FAK in MDCK cells was
approximately 2.5-fold of endogenous FAK (Fig.
3A). Cells from three WT
clones and a control (Neo) clone were exposed to UV radiation, and
their survival rates were determined after various time intervals. The
results showed that, 9, 12, or 24 h after UV irradiation, the
survival rate of WT cells was significantly (30-40%) higher than that
of control cells (Fig. 3B). To further confirm the
antiapoptotic effect of FAK in this system, other apoptotic
characteristics were analyzed. The Hoechst staining showed that, 4 h after UV irradiation, control cells contained a higher number of
apoptotic nuclei, manifested by shrunken and fragmented nuclear
morphology and condensed chromatin, than WT cells (Fig. 3C).
The DNA laddering assays indicated that control cells also exhibited a
more severe DNA fragmentation than WT cells upon UV irradiation (data
not shown). Together, these data indicate that overexpression of FAK is
able to suppress UV-induced apoptosis. A simple explanation for WT
cells being more resistant to UV irradiation is that more intact FAK
proteins retained in WT cells than in Neo cells within a period of time
after UV irradiation. To examine this, the cleavage of FAK in WT and
Neo cells were analyzed 9 h after UV irradiation (Fig.
3D). The result clearly supports our assumption and suggests
that the ability of FAK to exert its antiapoptotic function may first
rely on its intact structure.
|
To investigate the mechanisms by which FAK transmits survival signals
downstream, stable MDCK cell lines overexpressing FAK mutants including
D395A, Y397F, P712A/P715A, and Y925F, deficient in binding to PI3K,
Src, p130Cas, and Grb2, respectively, were established. The
expression levels of these FAK mutants were comparable with WT FAK
(Fig. 4B, top) and
all localized in focal contacts (data not shown). Interestingly, all of
these FAK mutants failed to promote cell survival upon UV irradiation
(Fig. 4A). To examine if these ectopically expressed FAK
proteins had a similar rate in their decay, presumably caused by
caspase-mediated cleavage, these stable MDCK cell lines were exposed to
UV radiation and lysed 4 or 6 h afterwards. Surprisingly, the
decay rates of FAK Y397F, P712A/P715A, and Y925F mutants were much
faster than those in both WT FAK and D395A mutant, which were similar
in their rates of decay (Fig. 4B). Six hours after UV
irradiation, HA-tagged FAK proteins were markedly lowered in Y397F,
P712A/P715A, and Y925F cells. Conversely, a substantial amount of
HA-tagged FAK proteins still remained intact in WT FAK and D395A cells
at this time point. Thus, it is possible that the failure of FAK Y397F,
P712A/P715A, and Y925F mutants in promoting cell survival is because of
their fast decay rates rather than deficiency in particular protein
binding. Nevertheless, the result showing FAK D395A failed to promote
cell survival suggested that PI3K binding might be required for FAK to
promote cell survival (see below).
|
Consistent with our previous result (17), FAK D395A mutant expressed in MDCK cells was able to bind Src and p130Cas and exhibited a level of tyrosine phosphorylation and in vitro autophosphorylation similar to WT FAK (data not shown). These results indicated that the amino acid substitution in D395A mutant did not cause a change in its conformation. Moreover, because D395A mutant has been shown to be deficient in binding to PI3K in vitro and in Chinese hamster cells (17), our results here strongly suggest that the direct binding of PI3K to FAK may be required for FAK to promote cell survival. To confirm this, the association of endogenous PI3K with WT FAK and D395A mutant upon UV irradiation in MDCK cells was examined (Fig. 4C). The level of PI3K activity associated with WT FAK was higher (~7-fold) than that associated with D395A mutant in MDCK cells. Although some residual binding of PI3K to FAK D395A mutant was detected, it was apparently not sufficient for promoting cell survival in this system.
It has previously been shown that associations of PI3K and
p130Cas are required for FAK to promote cell migration (16,
17). To examine if direct association of p130Cas with FAK
is also critical for FAK to suppress cell death induced by UV
irradiation, the HA-tagged SH3 domain of p130Cas (CasSH3)
was stably expressed in MDCK cells that had already expressed HA-tagged
FAK. CasSH3 was expected to function as a dominant-negative version of
p130Cas by competing with endogenous p130Cas
for FAK binding. The expression level of HA-tagged FAK in cells (WT/CasSH3) expressing both FAK and CasSH3 was similar to that in WT
cells (Fig. 5A). Next, we
examined the effect of CasSH3 expression on FAK associations with
p130Cas and PI3K. The results showed that the association
of endogenous p130Cas with HA-tagged FAK was significantly
reduced in WT/CasSH3 cells (Fig. 5B). Conversely, the
association of PI3K with HA-tagged FAK was not affected by CasSH3
expression (data not shown). Importantly, we found that WT/CasSH3
clones exhibited a lower cell survival rate than WT cells upon UV
irradiation (Fig. 5C), indicating that, in addition to PI3K,
p130Cas binding may be also required for FAK to promote
cell survival.
|
| |
DISCUSSION |
|---|
|
|
|---|
In this report, first we showed a sequential cleavage of FAK during UV-induced apoptosis. Because FAK cleavage is also triggered by other apoptotic stimuli in various cell types (24-27), it is possible that this proteolytic event is a general phenomenon in apoptosis and plays an important role in the execution of the suicide pathway. The cleavage of FAK during UV-induced apoptosis was completely inhibited by a general caspase inhibitor ZVAD-FMK and apparently delayed by Bcl2 expression, suggesting an involvement of caspases in this event. In fact, several members of the caspase family have been shown to directly cleave FAK in vitro (25, 27). Notably, the patterns of FAK cleavage in various cell types undergoing apoptosis induced by UV irradiation (Fig. 1) or other stimuli (24-27) were very similar, indicating that a similar, if not the same, set of caspases may be responsible for FAK cleavage in response to various apoptotic stimuli.
Among known FAK-interacting proteins, we found that Src and p130Cas were cleaved during UV-induced apoptosis. The cleavage of Src could be completely blocked by a caspase-3 inhibitor DEVD-CHO at 40 µM, which could only partially inhibit cleavage of FAK and p130Cas (Fig. 2). These results suggest that only caspase-3-like caspase(s) may be responsible for Src cleavage during UV-induced apoptosis. Moreover, our results showed that a substantial amount of Src remained intact 24 h (Fig. 1) or even 36 h (data not shown) after UV irradiation, indicating that Src cleavage occurred only in part of its fractions. Src is mainly a membrane protein, anchored via an N-terminal myristic acid and neighboring positively charged amino acids (30). To examine if membrane association protects Src from caspase-mediated cleavage, we carried out subcellular fractionation for UV-irradiated MDCK cells. Our preliminary results showed that Src cleavage was observed in cytosol fractions, but not in membrane fractions (data not shown). These results raise an intriguing possibility that, in addition to the presence of specific motifs in substrates for caspase recognition, subcellular localization and/or membrane anchorage of caspase substrates may have some impact on the execution of the proteolysis.
In this study, we have established stable MDCK cell lines overexpressing FAK or its mutants deficient in binding to PI3K, Src, p130Cas, or Grb2. Surprisingly, these ectopically expressed FAK proteins exhibited different rates in their decay during UV-induced apoptosis (Fig. 4), presumably due to a caspase-mediated cleavage. It appeared that Y397F, P712A/P715A, and Y925F mutants had a faster decay rate than both WT FAK and D395A mutant, which were similar in their rates of decay. Although the reason for this is unclear at present, it is possible that protein-protein interactions may lead to a mask of caspase recognition motifs on FAK or block the access of caspase to FAK, thereby tentatively protecting FAK from cleavage. Alternatively, the amino acid substitutions in FAK mutants Y397F, P712A/P715A, or Y925F may cause a change in protein conformation, leading to protein less stable regardless of UV irradiation. The latter possibility was excluded by our observation that all FAK mutants used in this study had a turnover rate similar to WT without UV irradiation (data not shown). It is noteworthy that, like WT, all FAK mutants described in this report targeted to focal adhesions (data not shown), rendering it unlikely that a faster decay rate for certain FAK mutants is due to an incorrect subcellular localization.
Despite the fact that expression of the constitutively activated form of FAK rescues MDCK cells from apoptosis induced by the disruption of cell-matrix interactions (10), here we show the first time that expression of WT FAK can significantly (30-40%) promote cell survival upon UV irradiation (Fig. 3). In addition to UV irradiation, these FAK-overexpressed cells were also found to be more resistant to some tested apoptotic stimuli, such as treatment of cyclohexamide and loss of cell-matrix adhesion (data not shown). Using this system, we further showed that a PI3K binding-deficient mutant (D395A) that had a decay rate similar to WT FAK upon UV irradiation failed to promote cell survival (Fig. 4). Because, except for deficiency in PI3K binding, no other changes could be detected for the D395A mutant, including the ability to bind other FAK-interacting proteins and the level of tyrosine phosphorylation and in vitro kinase activity, our results strongly suggest that PI3K binding is required for FAK to promote cell survival. In fact, an increased association of FAK with PI3K and a subsequent activation of Akt have been observed in hydrogen peroxide-induced apoptosis in human glioblastoma cells (31). This and our results are consistent with other work showing the importance of PI3K in promoting cell survival (32-34).
Although a FAK mutant (P712A/P715A) deficient in p130Cas binding failed to promote cell survival upon UV irradiation, we could not conclude that p130Cas binding is required for FAK to promote cell survival because of the fast decay rate of this mutant during UV-induced apoptosis (Fig. 4). Thus, we employed another strategy to examine the potential role of p130Cas in FAK-promoted cell survival. We showed that expression of the SH3 domain of p130Cas was able to interfere with FAK-p130Cas association and to suppress cell survival promoted by FAK overexpression (Fig. 5). These results suggest that, in addition to PI3K, p130Cas binding is also required for FAK to promote cell survival. Ilic et al. (9) showed that two FAK C-terminal constructs, FAK-related nonkinase and the FAT domain, were localized in focal adhesions and displaced endogenous FAK from these sites, but only the FAT domain was able to abrogate the function of FAK to transduce survival signals from fibronectin. These results suggest that FAK-related nonkinase, but not the FAT domain, may contain sequences required for FAK to promote cell survival. A comparison between these two constructs revealed that an N-terminal region of FAK-related nonkinase comprising a proline-rich sequence for p130Cas binding was not present in the FAT domain, supporting the notion that p130Cas binding is required for FAK to promote cell survival. In fact, it has been proposed that the initial cleavage of FAK at Asp-772 by caspase-3-like proteases may generate a FAK C-terminal fragment corresponding to the FAT domain, which may act as a competitive inhibitor for the remaining intact FAK during apoptosis (27).
The adaptor protein p130Cas was originally identified as a major tyrosine-phosphorylated protein in cells transformed by either v-src (35-37) or v-crk (38-40). Its association with another adaptor protein Crk has been shown to play an important role in promoting cell migration (41). Our results in this report imply that p130Cas may also have a function in regulating cell survival. It has recently been shown that p130Cas-Crk association further leads to activation of c-Jun N-terminal kinase via small GTP-binding protein Rac (42, 43). It will be of interest to determine the potential connection between the c-Jun N-terminal kinase activation and p130Cas-mediated cell migration and/or cell survival.
Because the effect of FAK on the suppression of UV-induced apoptosis is
limited (~30%), apparently other survival factors against UV-induced
apoptosis are present. In fact, the first cellular response detectable
in UV-irradiated cells is the tyrosine phosphorylation of different
cell membrane growth factor receptors (44). It has been shown that UV
rapidly induces activation of Ras, Src, and other molecules located at
or near the plasma membrane (45, 46) and inhibition of tyrosine
phosphatases (47), leading to signaling and to transcription of
UV-responsive genes. Recently, the atypical protein kinase C (PKC)
isoforms, PKC
and PKC
/
, have been suggested to play a
protective role in UV-induced apoptosis (48, 49). It was found that
overexpression of PKC
and PKC
/
inhibited UV-induced cell
death, whereas exposure of cells to UV radiation leads to a dramatic
reduction of PKC
activity (48). Furthermore, it is known that UV
irradiation potently activates c-Jun N-terminal kinase (50). The
UV-induced c-Jun N-terminal kinase activation has also been suggested
to trigger a protective response through the activation of genes coding
for protective proteins (45, 50, 51). Therefore, the signaling
cascades induced by UV radiation appear to be complex and involve many different molecules. Some of them promote survival, whereas others promote cell death. The relationship between FAK and other survival factors in UV-induced apoptosis remains to be investigated.
| |
ACKNOWLEDGEMENT |
|---|
We thank Dr. J.-L. Guan for the plasmid pKH3-CasSH3.
| |
FOOTNOTES |
|---|
* This research was supported by National Health Research Institutes, Taiwan, Grant NHRI-GT-EX89S919C (to H.-C. C.) and National Science Council, Taiwan, Grant NSC88-2314-BO75A-016 (to C.-H. C.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
** To whom correspondence should be addressed. Tel.: 886-4-2854922; Fax: 886-4-2851797; E-mail: hcchen@nchu.edu.tw.
| |
ABBREVIATIONS |
|---|
The abbreviations used are: FAK, focal adhesion kinase; SH2 and -3, Src homology 2 and 3, respectively; FAT, focal adhesion targeting; WT, wild type; HA, hemagglutinin; MDCK, Madin-Darby canine kidney; PKC, protein kinase C; PI3K, phosphatidylinositol 3-kinase; DEVD-CHO, N-acetyl-Asp-Glu-Val-Asp-aldehyde; ZVAD-FMK, benzyloxycarbonyl-Val-Ala-Asp fluoromethyl ketone.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Schwartz, M. A., Schaller, M. D., and Ginsberg, M. H. (1995) Annu. Rev. Cell Dev. Biol. 11, 549-599[CrossRef][Medline] [Order article via Infotrieve] |
| 2. | Parsons, J. T. (1996) Curr. Opin. Cell Biol. 8, 146-152[CrossRef][Medline] [Order article via Infotrieve] |
| 3. | Guan, J.-L., and Chen, H.-C. (1996) Int. Rev. Cytol. 168, 81-108[Medline] [Order article via Infotrieve] |
| 4. | Ilic, D., Furuta, Y., Kanazawa, S., Takeda, N., Sobue, K., Nakatsuji, N., Nomura, S., Fujimoto, J., Okada, M., Yamamoto, T., and Aizawa, S. (1995) Nature 377, 539-543[CrossRef][Medline] [Order article via Infotrieve] |
| 5. | Cary, L. A., Chang, J. F., and Guan, J.-L. (1996) J. Cell Sci. 109, 1787-1794[Abstract] |
| 6. |
Zhao, J.-H.,
Reiske, H.,
and Guan, J.-L.
(1998)
J. Cell Biol.
143,
1997-2008 |
| 7. |
Hungerford, J. E.,
Compton, M. T.,
Matter, M. L.,
Hoffstrom, B. G.,
and Otey, C.
(1996)
J. Cell Biol.
135,
1383-1390 |
| 8. | Xu, L., Owens, L. V., Sturge, G. C., Yang, X., Liu, E. T., Craven, R. J., and Cance, W. G. (1996) Cell Growth & Differ. 7, 413-418[Abstract] |
| 9. |
Ilic, D.,
Almeida, E. A. C.,
Schlaepfer, D. D.,
Dazin, P.,
Aizawa, S.,
and Damsky, C. H.
(1998)
J. Cell Biol.
143,
547-560 |
| 10. |
Frisch, S. M.,
Vuori, K.,
Ruoslahti, E.,
and Chan-Hui, P.-Y.
(1996)
J. Cell Biol.
134,
793-799 |
| 11. | Xing, Z., Chen, H.-C., Nowlen, J. K., Taylor, S., Shalloway, D., and Guan, J.-L. (1994) Mol. Biol. Cell 5, 413-421[Abstract] |
| 12. |
Cobb, B. S.,
Schaller, M. D.,
Leu, T.-H.,
and Parsons, J. T.
(1994)
Mol. Cell. Biol.
14,
147-155 |
| 13. |
Chen, H.-C.,
and Guan, J.-L.
(1994)
Proc. Natl. Acad. Sci. U. S. A.
91,
10148-10152 |
| 14. | Schlaepfer, D. D., Hanks, S. K., Hunter, T., and van der Geer, P. (1994) Nature 372, 786-791[Medline] [Order article via Infotrieve] |
| 15. |
Polte, T. R.,
and Hanks, S. K.
(1995)
Proc. Natl. Acad. Sci. U. S. A.
92,
10678-10682 |
| 16. |
Cary, L. A.,
Han, D. C.,
Polte, T. R.,
Hanks, S. K.,
and Guan, J.-L.
(1998)
J. Cell Biol.
140,
211-221 |
| 17. |
Reiske, H. R.,
Kao, S.-C.,
Cary, L. A.,
Guan, J.-L.,
Lai, J.-F.,
and Chen, H.-C.
(1999)
J. Biol. Chem.
274,
12361-12366 |
| 18. |
Schaller, M. D.,
Hildebrand, J. D.,
Shannon, J. D.,
Fox, J. X.,
Vines, R. R.,
and Parsons, J. T.
(1994)
Mol. Cell. Biol.
14,
1680-1688 |
| 19. |
Chen, H.-C.,
Appeddu, P. A.,
Isoda, H.,
and Guan, J.-L.
(1996)
J. Biol. Chem.
271,
26329-26334 |
| 20. | Schlaepfer, D. D., and Hunter, T. (1996) Mol. Cell. Biol. 16, 5623-5633[Abstract] |
| 21. |
Harte, M. T.,
Hildebrand, J. D.,
Burnham, M. R.,
Bouton, A. H.,
and Parsons, J. T.
(1996)
J. Biol. Chem.
271,
13649-13655 |
| 22. |
Tang, M.-J.,
Hu, J.-J.,
Lin, H.-H.,
Chiu, W.-T.,
and Jiang, S.-T.
(1998)
Am. J. Physiol.
275,
C921-C931 |
| 23. |
Chen, H.-C.,
Chan, P.-C.,
Tang, M.-J.,
Cheng, C.-H.,
and Chang, T.-J.
(1998)
J. Biol. Chem.
273,
25777-25782 |
| 24. |
Levkau, B.,
Herren, B.,
Koyama, H.,
Ross, R.,
and Raines, E.
(1998)
J. Exp. Med.
187,
579-586 |
| 25. |
Wen, L.-P.,
Fahrni, J. A.,
Troie, S.,
Guan, J.-L.,
Orth, K.,
and Rosen, G. D.
(1997)
J. Biol. Chem.
272,
26056-26061 |
| 26. | Crouch, D. H., Fincham, V. J., and Frame, M. C. (1996) Oncogene 12, 2689-2696[Medline] [Order article via Infotrieve] |
| 27. |
Gervais, F. G.,
Thornberry, N. A.,
Ruffolo, S. S.,
Nicholson, D. W.,
and Roy, S.
(1998)
J. Biol. Chem.
273,
17102-17108 |
| 28. | Shimizu, S., Eguchi, Y., Kamiike, W., Matsuda, H., and Tsujimoto, Y. (1996) Oncogene 12, 2251-2257[Medline] [Order article via Infotrieve] |
| 29. |
Chinnaiyan, A. M.,
Orth, K.,
Orouke, K.,
Duan, H.,
Poirier, G. G.,
and Dixit, V. M.
(1996)
J. Biol. Chem.
271,
4573-4576 |
| 30. | Rech, M. D. (1994) Cell 76, 411-413 |
| 31. |
Sonoda, Y.,
Watanabe, S.,
Matsumoto, Y.,
Aizu-Yokota, E.,
and Kasahara, T.
(1999)
J. Biol. Chem.
274,
10566-10570 |
| 32. |
Yao, R.,
and Cooper, G. M.
(1995)
Science
267,
2003-2006 |
| 33. |
Dudek, H.,
Datta, S. R.,
Franke, T. F.,
Birnbaum, M. J.,
Yao, R.,
Cooper, G. M.,
Segal, R. A.,
Kaplan, D. R.,
and Greenberg, M. E.
(1997)
Science
275,
661-665 |
| 34. | Kulik, G., Klippel, A., and Weber, M. J. (1997) Mol. Cell. Biol. 17, 1595-1606[Abstract] |
| 35. |
Reynolds, A. B.,
Kanner, S. B.,
Wang, H.-C. R.,
and Parsons, J. T.
(1989)
Mol. Cell. Biol.
9,
3951-3958 |
| 36. |
Kanner, S. B.,
Reynolds, A. B.,
Vines, R. R.,
and Parsons, J. T.
(1990)
Proc. Natl. Acad. Sci. U. S. A.
87,
3328-3332 |
| 37. | Kanner, S. B., Reynolds, A. B., Wang, H.-C. R., Vines, R. R., and Parsons, J. T. (1991) EMBO J. 10, 1689-1698[Medline] [Order article via Infotrieve] |
| 38. |
Mayer, B. J.,
and Hanafusa, H.
(1990)
Proc. Natl. Acad. Sci. U. S. A.
87,
2638-2642 |
| 39. |
Matsuda, M.,
Mayer, B. J.,
Fukui, Y.,
and Hanafusa, H.
(1990)
Science
248,
1537-1539 |
| 40. |
Birge, R. B.,
Fajardo, J. E.,
Mayer, B. J.,
and Hanafusa, H.
(1992)
J. Biol. Chem.
267,
10588-10595 |
| 41. |
Klemke, R. L.,
Leng, J.,
Molander, R.,
Brooks, P. C.,
Vuori, K.,
and Cheresh, D. A.
(1998)
J. Cell Biol.
140,
961-972 |
| 42. |
Dolfi, F.,
Garcia-Guzman, M.,
Ojaniemi, M.,
Nakamura, H.,
Matsuda, M.,
and Vuori, K.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
15394-15399 |
| 43. |
Kiyokawa, E.,
Hashimoto, Y.,
Kobayashi, S.,
Sugimura, H.,
Kurata, T.,
and Matsuda, M.
(1998)
Genes Dev.
12,
3331-3336 |
| 44. | Sachsenmaier, C. A., Radler-Pohl, A., Zinck, R., Nordheim, A., Herrlich, P., and Rahmsdorf, H. J. (1994) Cell 78, 963-972[CrossRef][Medline] [Order article via Infotrieve] |
| 45. | Devary, Y., Gottlieb, R. A., Smeal, T., and Karin, M. (1992) Cell 71, 1081-1091[CrossRef][Medline] [Order article via Infotrieve] |
| 46. |
Devary, Y.,
Rosette, C.,
DiDonato, J. A.,
and Karin, M.
(1993)
Science
261,
1442-1445 |
| 47. | Knebel, A., Rahmsdorf, H. J., Ullrich, A., and Herrlich, P. (1996) EMBO J. 15, 5314-5325[Medline] [Order article via Infotrieve] |
| 48. | Diaz-Meco, M. T., Municio, M. M., Frutos, S., Sanchez, P., Lozano, J., Sanz, L., and Moscat, J. (1996) Cell 86, 777-786[CrossRef][Medline] [Order article via Infotrieve] |
| 49. | Berra, E., Municio, M. M., Sanz, L., Frutos, S., Diaz-Meco, M. T., and Moscat, J. (1997) Mol. Cell. Biol. 17, 4346-4354[Abstract] |
| 50. | Derijard, B., Hibi, M., Wu, I.-H., Barrett, T., Su, B., Deng, T., Karin, M., and Davis, R. J. (1994) Cell 76, 1025-1037[CrossRef][Medline] [Order article via Infotrieve] |
| 51. | Kyriakis, J. M., Banerjee, P., Nikolakaki, E., Dai, T., Rubie, E. A., Ahmad, M. F., Avruch, J., and Woodgett, J. R. (1994) Nature 369, 156-160[CrossRef][Medline] [Order article via Infotrieve] |
This article has been cited by other articles:
![]() |
Y. Sekine, S. Tsuji, O. Ikeda, K. Sugiyma, K. Oritani, K. Shimoda, R. Muromoto, N. Ohbayashi, A. Yoshimura, and T. Matsuda Signal-Transducing Adaptor Protein-2 Regulates Integrin-Mediated T Cell Adhesion through Protein Degradation of Focal Adhesion Kinase J. Immunol., August 15, 2007; 179(4): 2397 - 2407. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Lunn, R. Jacamo, and E. Rozengurt Preferential Phosphorylation of Focal Adhesion Kinase Tyrosine 861 Is Critical for Mediating an Anti-apoptotic Response to Hyperosmotic Stress J. Biol. Chem., April 6, 2007; 282(14): 10370 - 10379. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Huang, M. Khoe, M. Befekadu, S. Chung, Y. Takata, D. Ilic, and M. Bryer-Ash Focal adhesion kinase mediates cell survival via NF-{kappa}B and ERK signaling pathways Am J Physiol Cell Physiol, April 1, 2007; 292(4): C1339 - C1352. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Wei, W. Campbell, and R. S. Vander Heide Heat shock-induced cardioprotection activates cytoskeletal-based cell survival pathways Am J Physiol Heart Circ Physiol, August 1, 2006; 291(2): H638 - H647. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Gonzalez, M. T. Agullo-Ortuno, J. M. Garcia-Martinez, A. Calcabrini, C. Gamallo, J. Palacios, A. Aranda, and J. Martin-Perez Role of c-Src in Human MCF7 Breast Cancer Cell Tumorigenesis J. Biol. Chem., July 28, 2006; 281(30): 20851 - 20864. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ohnishi, G. Hasegawa, M. Yamasaki, H. Obayashi, M. Fukui, T. Nakajima, Y. Ichida, H. Ohse, S.-i. Mogami, T. Yoshikawa, et al. Integrin-linked kinase acts as a pro-survival factor against high glucose-associated osmotic stress in human mesangial cells Nephrol. Dial. Transplant., July 1, 2006; 21(7): 1786 - 1793. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. M. Zhang, K. M. Keledjian, J. N. Rao, T. Zou, L. Liu, B. S. Marasa, S. R. Wang, L. Ru, E. D. Strauch, and J.-Y. Wang Induced focal adhesion kinase expression suppresses apoptosis by activating NF-{kappa}B signaling in intestinal epithelial cells Am J Physiol Cell Physiol, May 1, 2006; 290(5): C1310 - C1320. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Aixinjueluo, K. Furukawa, Q. Zhang, K. Hamamura, N. Tokuda, S. Yoshida, R. Ueda, and K. Furukawa Mechanisms for the Apoptosis of Small Cell Lung Cancer Cells Induced by Anti-GD2 Monoclonal Antibodies: ROLES OF ANOIKIS J. Biol. Chem., August 19, 2005; 280(33): 29828 - 29836. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Grigoriou, I. M. Shapiro, E. A. Cavalcanti-Adam, R. J. Composto, P. Ducheyne, and C. S. Adams Apoptosis and Survival of Osteoblast-like Cells Are Regulated by Surface Attachment J. Biol. Chem., January 21, 2005; 280(3): 1733 - 1739. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Peng, H. Ueda, H. Zhou, T. Stokol, T.-L. Shen, A. Alcaraz, T. Nagy, J.-D. Vassalli, and J.-L. Guan Overexpression of focal adhesion kinase in vascular endothelial cells promotes angiogenesis in transgenic mice Cardiovasc Res, December 1, 2004; 64(3): 421 - 430. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Lunn and E. Rozengurt Hyperosmotic Stress Induces Rapid Focal Adhesion Kinase Phosphorylation at Tyrosines 397 and 577: ROLE OF Src FAMILY KINASES AND Rho FAMILY GTPases J. Biol. Chem., October 22, 2004; 279(43): 45266 - 45278. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-L. Lee, C.-T. Lin, L.-L. Chueh, and C.-J. Chang Autocrine/Paracrine Secreted Frizzled-related Protein 2 Induces Cellular Resistance to Apoptosis: A POSSIBLE MECHANISM OF MAMMARY TUMORIGENESIS J. Biol. Chem., April 9, 2004; 279(15): 14602 - 14609. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Romero, A. M. Gil-Bernabe, C. Saez, M. A. Japon, J. A. Pintor-Toro, and M. Tortolero Securin Is a Target of the UV Response Pathway in Mammalian Cells Mol. Cell. Biol., April 1, 2004; 24(7): 2720 - 2733. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Kim, S. Kook, D. J. Kim, C. Teodorof, and W. K. Song The 31-kDa Caspase-generated Cleavage Product of p130cas Functions as a Transcriptional Repressor of E2A in Apoptotic Cells J. Biol. Chem., February 27, 2004; 279(9): 8333 - 8342. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Bezzi, M. Hasmim, G. Bieler, O. Dormond, and C. Ruegg Zoledronate Sensitizes Endothelial Cells to Tumor Necrosis Factor-induced Programmed Cell Death: EVIDENCE FOR THE SUPPRESSION OF SUSTAINED ACTIVATION OF FOCAL ADHESION KINASE AND PROTEIN KINASE B/Akt J. Biol. Chem., October 31, 2003; 278(44): 43603 - 43614. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Funakoshi-Tago, Y. Sonoda, S. Tanaka, K. Hashimoto, K. Tago, S.-i. Tominaga, and T. Kasahara Tumor Necrosis Factor-induced Nuclear Factor {kappa}B Activation Is Impaired in Focal Adhesion Kinase-deficient Fibroblasts J. Biol. Chem., August 1, 2003; 278(31): 29359 - 29365. [Abstract] [Full Text] [PDF] |
||||
![]() |